These researchers also explored the role of DNA-PKcs in the changes in telomere length mediated by thymoquinone, and they discovered that glioblastoma cells with DNA-PKcs were more responsive to thymoquinone-induced effects compared to cells lacking DNA-PKcs [19]. The gene discussed is PRKDC; the disease is glioblastoma.